Detailed information for compound 1795658

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 400.516 | Formula: C25H28N4O
  • H donors: 0 H acceptors: 2 LogP: 2.98 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C1N(CCC21CCN(CC2)Cc1nccn1C)c1ccc(cc1)c1ccccc1
  • InChi: 1S/C25H28N4O/c1-27-18-14-26-23(27)19-28-15-11-25(12-16-28)13-17-29(24(25)30)22-9-7-21(8-10-22)20-5-3-2-4-6-20/h2-10,14,18H,11-13,15-17,19H2,1H3
  • InChiKey: QFZKAEGCEQQJEP-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens egl-9 family hypoxia-inducible factor 1 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_131326 All targets in OG5_131326
Neospora caninum 2OG-Fe(II) oxygenase family protein, putative Get druggable targets OG5_131326 All targets in OG5_131326
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trypanosoma cruzi mitochondrial structure specific endonuclease I (SSE-1), putative 0.004 0.007 0.0259
Loa Loa (eye worm) hypothetical protein 0.0305 0.0892 1
Giardia lamblia Telomerase catalytic subunit 0.0887 0.2692 0.5
Mycobacterium ulcerans DNA polymerase I 0.0056 0.012 1
Toxoplasma gondii RNA-directed DNA polymerase 0.0887 0.2692 1
Trypanosoma cruzi telomerase reverse transcriptase, putative 0.0887 0.2692 1
Trypanosoma cruzi telomerase reverse transcriptase, putative 0.0887 0.2692 1
Plasmodium vivax telomerase reverse transcriptase, putative 0.0887 0.2692 1
Trypanosoma brucei telomerase reverse transcriptase 0.0887 0.2692 1
Mycobacterium tuberculosis Probable DNA polymerase I PolA 0.0056 0.012 1
Echinococcus multilocularis prolyl 4 hydroxylase subunit alpha 1 0.0017 0 0.5
Leishmania major telomerase reverse transcriptase, putative 0.0887 0.2692 1
Trypanosoma cruzi mitochondrial structure specific endonuclease I (SSE-1), putative 0.004 0.007 0.0259
Toxoplasma gondii 5'-3' exonuclease, N-terminal resolvase family domain-containing protein 0.002 0.0007 0.0025
Plasmodium falciparum telomerase reverse transcriptase 0.0887 0.2692 1
Schistosoma mansoni prolyl 4-hydroxylase alpha subunit 1 0.0017 0 0.5
Wolbachia endosymbiont of Brugia malayi DNA polymerase I 0.0056 0.012 0.5
Brugia malayi Telomerase reverse transcriptase 0.236 0.7254 1
Treponema pallidum DNA polymerase I (polA) 0.0056 0.012 0.5
Trypanosoma brucei mitochondrial structure specific endonuclease I (SSE-1), putative 0.004 0.007 0.0259
Echinococcus granulosus prolyl 4 hydroxylase subunit alpha 1 0.0017 0 0.5
Leishmania major mitochondrial structure specific endonuclease I (SSE-1), putative 0.004 0.007 0.0259
Chlamydia trachomatis DNA polymerase I 0.0056 0.012 0.5
Mycobacterium leprae PROBABLE DNA POLYMERASE I POLA 0.0056 0.012 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 7.8 Inhibition of PHD2 (unknown origin) by HTRF assay ChEMBL. 24055079

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.